Trial Profile
A randomized double blind, placebo controlled study to evaluate the efficacy and security of immunotherapy with a depigmented and polymerized allergen extract of Dermatophagoides pteronyssinus in patients with asthma.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 22 Jun 2011
Price :
$35
*
At a glance
- Drugs House dust mite allergy immunotherapy Laboratorios LETI (Primary) ; House dust mite allergy immunotherapy Laboratorios LETI (Primary)
- Indications Allergic asthma; Hypersensitivity
- Focus Therapeutic Use
- Sponsors Laboratorios LETI
- 22 Jun 2011 New trial record